Tumor-to-Tumor Metastasis Involving Vestibular Schwannoma: Case Report and Literature Review.

Otol NeurotolJun 12, 2026 (epub)

Patrick R Toyota, Celine D Hounjet, Eva Liu et al.

✦ AI-curated · Sources linked

Case in brief

A 55-year-old female with a history of invasive ductal breast carcinoma presented with unilateral hearing loss and gait disturbance. MRI revealed a right-sided extra-axial cerebellopontine angle lesion, leading to surgical resection. Histopathological analysis confirmed the presence of vestibular schwannoma with glandular elements, indicating metastasis from her breast cancer. Staging imaging subsequently revealed advanced oncologic spread.

What made this case unusual

This case highlights tumor-to-tumor metastasis involving vestibular schwannoma, a rare phenomenon where a known malignancy metastasizes to a benign tumor.

Diagnostic / clinical pearl

Clinicians should consider the possibility of tumor-to-tumor metastasis in patients with vestibular schwannoma who have a history of systemic malignancy.

Why it matters

Understanding the mechanisms of tumor-to-tumor metastasis can enhance the management of patients with concurrent malignancies and benign tumors.

Source

Published in Otol Neurotol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.